Veradigm | MDRX - Market Capitalization


Veradigm reported $493.2M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alcidion AUD 141.01M 6.71M Dec/2025
Ambu A/S DKK 16.43B 1.99B Jun/2026
Amplifon EUR 2.57B 504.52M Jun/2026
Cardinal Health USD 55.64B 5.92B Jun/2026
Centene USD 31.7B 15.53B Jun/2026
Charles River Laboratories USD 10.39B 2.54B Jun/2026
Cigna USD 72.93B 2.59B Jun/2026
Coloplast 124.69B 775.88M Dec/2025
CVS Health USD 132B 39.95B Jun/2026
Elevance Health USD 83.98B 19.68B Jun/2026
General Electric Aerospace USD 389.93B 93.44B Jun/2026
Gulf Medical Proj AED 1.67B 314.51M Mar/2026
Humana USD 47.69B 26.88B Jun/2026
IQVIA Holdings USD 32.25B 3.62B Jun/2026
Laboratory Of America USD 22.96B 1.03B Jun/2026
Maximus USD 2.82B 672M Jun/2026
McKesson USD 88.46B 17.53B Jun/2026
Med Life RON 6.23B 2.07B Mar/2026
Molina Healthcare USD 11.92B 4.97B Jun/2026
Omnicell USD 1.89B 370M Jun/2026
Oriola-kd EUR 175.13M 37.99M Mar/2026
Owens Minor USD 217M 154M Dec/2025
Quest Diagnostics USD 23.46B 1.77B Jun/2026
Rede D'or Sao Luiz BRL 77.76B 11.45B Jun/2026
Supermax Corporation Bhd MYR 932.46M 161.22M Mar/2026
UnitedHealth USD 377.45B 131.84B Jun/2026
Veeva Systems USD 33.1B 7.65B Jun/2026
Veradigm USD 525M 621M Mar/2026